Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Kieran Foley"'
Autor:
Craig Parkinson, Kieran Foley, Philip Whybra, Robert Hills, Ashley Roberts, Chris Marshall, John Staffurth, Emiliano Spezi
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-9 (2018)
Abstract Background Prognosis in oesophageal cancer (OC) is poor. The 5-year overall survival (OS) rate is approximately 15%. Personalised medicine is hoped to increase the 5- and 10-year OS rates. Quantitative analysis of PET is gaining substantial
Externí odkaz:
https://doaj.org/article/9df531033e3f40ef86a5faf8526e3fa5
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225550 (2019)
The aim of this work was to investigate radiomic analysis of contrast and non-contrast enhanced planning CT images of oesophageal cancer (OC) patients in terms of stability, dimensionality and contrast agent dependency. The prognostic significance of
Externí odkaz:
https://doaj.org/article/4b5c76f247d049fead0b1cb76a6d5276
Autor:
Tracey England, Kieran Foley, Tom Crosby, Daniel Gartner, Paul Robert Harper, Edilson F. Arruda, Ian Williamson
Publikováno v:
Journal of Simulation. 17:94-104
The United Kingdom has one of the poorest lung cancer survival rates in Europe. In this study, to help design and evaluate a single lung cancer pathway (SCP) for Wales, existing diagnostic pathways and processes have been mapped and then modelled wit
Autor:
Richard C. Turkington, Kieran Foley, Kevin M. Bradley, Richard D. Kennedy, David Campbell, Martin Eatock, Eoin Napier, Anita Lavery
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Foley, K G, Lavery, A, Napier, E, Campbell, D, Eatock, M M, Kennedy, R D, Bradley, K M & Turkington, R C 2021, ' A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma ', Scientific Reports, vol. 11, no. 1, 13061 . https://doi.org/10.1038/s41598-021-92545-w
Scientific Reports
Foley, K G, Lavery, A, Napier, E, Campbell, D, Eatock, M M, Kennedy, R D, Bradley, K M & Turkington, R C 2021, ' A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma ', Scientific Reports, vol. 11, no. 1, 13061 . https://doi.org/10.1038/s41598-021-92545-w
Scientific Reports
18F-fluorodeoxyglucose PET-CT may guide treatment decisions in patients with oesophageal adenocarcinoma (OAC). This study evaluated the added value of maximum standardised uptake value (SUVmax) to a novel DNA-damage immune response (DDIR) assay to im
Chapter 7 discusses oesophageal tumours, including clinical background, diagnosis and staging, planning, therapeutic assessment, and follow-up. Patients with oesophageal cancer have a poor prognosis because many present with advanced disease. Accurat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9bd4306b66107c3721ef0b577bcd364
https://doi.org/10.1093/med/9780198818502.003.0007
https://doi.org/10.1093/med/9780198818502.003.0007
Publikováno v:
Clinical Radiology. 77:e21
Autor:
Petros Kalendralis, Ruben T. H. M. Larue, Leonard Wee, Craig Parkinson, Stuart A. G. Roberts, John Staffurth, Maaike Berbee, Meindert N. Sosef, Andre Dekker, Philip Whybra, Emiliano Spezi, Kieran Foley, Tom Crosby, Zhenwei Shi
Publikováno v:
Radiotherapy and Oncology, 133, 205-212. Elsevier Ireland Ltd
Aim: Enhanced prognostic models are required to improve risk stratification of patients with oesophageal cancer so treatment decisions can be optimised. The primary aim was to externally validate a published prognostic model incorporating PET image f
Publikováno v:
Radiography (London, England : 1995). 27
Objective\ud Radiation oncology is a continually evolving speciality. With the development of new imaging modalities and advanced imaging processing techniques, there is an increasing amount of data available to practitioners. In this narrative revie
Autor:
Daniel Gartner, Syaribah Noor Brice, Edilson F. Arruda, Tracey England, Emma Aspland, Paul Robert Harper, Kieran Foley, Tom Crosby
PurposeThe study aims to summarise the literature on cancer care pathways at the diagnostic and treatment phases. The objectives are to find factors influencing the delivery of cancer care pathways; to highlight any interrelating factors; to find gap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e8c45f5ba8d044aa4dea3abb01b573
https://orca.cardiff.ac.uk/id/eprint/139944/7/10-1108_JHOM-05-2020-0192.pdf
https://orca.cardiff.ac.uk/id/eprint/139944/7/10-1108_JHOM-05-2020-0192.pdf
Autor:
Ashley Roberts, Wyn G. Lewis, Maaike Berbee, Zhenwei Shi, Craig Parkinson, Emiliano Spezi, Andre Dekker, Adam Christian, Phil Whybra, Petros Kalendralis, Chong Zhang, Leonard Wee, Tom Crosby, Kieran Foley
Publikováno v:
British Journal of Radiology, 94(1118):20201042. British Institute of Radiology
Br J Radiol
Br J Radiol
Objectives: To improve clinical lymph node staging (cN-stage) in oesophageal adenocarcinoma by developing and externally validating three prediction models; one with clinical variables only, one with positron emission tomography (PET) radiomics only,